SCHEMBL7300140

SCHEMBL7300140

O=C(O)CCCn1c(=O)[nH]c(=O)c2ccccc21

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 3/20 0.68
FABP5 Q01469 3/20 0.68
KDM4E B2RXH2 4/20 0.63
HSD17B10 Q99714 2/20 0.63
MAPK1 P28482 1/20 0.63
PARP1 P09874 6/20 0.56
FABP3 P05413 1/20 0.54
ALDH1A1 P00352 2/20 0.51
HPGD P15428 1/20 0.51
LCK P06239 1/20 0.50
PRKACA P17612 1/20 0.50
CSNK2A2 P19784 1/20 0.50
PRKACG P22612 1/20 0.50
PRKACB P22694 1/20 0.50
GSK3B P49841 1/20 0.50
CSNK2B P67870 1/20 0.50
CSNK2A1 P68400 1/20 0.50
DYRK1A Q13627 1/20 0.50
CSNK2A3 Q8NEV1 1/20 0.50
CTNNB1 P35222 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13799882 0.91 FABP4 (0.66) FABP4FABP5KDM4EPARP1FABP3
SCHEMBL11009779 0.84 ALDH1A1 (0.60) FABP4FABP5MAPK1PARP1ALDH1A1
SCHEMBL97551 0.82 MAPK1 (0.70) FABP4FABP5KDM4EHSD17B10MAPK1
SCHEMBL7298333 0.82 ALDH1A1 (0.55) FABP4FABP5MAPK1PARP1ALDH1A1
SCHEMBL30530511 0.82 MAPK1 (0.70) FABP4FABP5KDM4EHSD17B10MAPK1
SCHEMBL8377270 0.82 KDM4E (0.64) KDM4EMAPK1PARP1ALDH1A1LCK
SCHEMBL7308089 0.82 TNF (0.62) KDM4EHSD17B10PARP1CTNNB1
SCHEMBL4314440 0.81 FABP4 (1.00) FABP4FABP5KDM4EHSD17B10MAPK1
SCHEMBL30573159 0.81 FABP4 (1.00) FABP4FABP5KDM4EHSD17B10MAPK1
SCHEMBL7299674 0.81 KDM4E (0.48) FABP4FABP5KDM4EHSD17B10MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5304560-A Treating CNS disorders; dopamine receptor antagonist FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-04-19 US disclosed
EP-0481342-A1 Quinazoline derivatives and their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-04-22 EP disclosed